Searched for
ONCOLOGY
- Apollo Hospitals plans to add 5,800 beds over next five years, Gurugram facility to open in Q3 FY27Apollo Hospitals is set to enhance its capacity by adding around 5,800 beds within the next five years. Their Gurugram facility, featuring ...
Zydus Q2 profit falls 27% despite 29% revenue growth; consumer wellness sales surge 76%Zydus Lifesciences reported a 29% year-on-year rise in Q2FY27 revenue to Rs 7,909 crore, driven by growth across key markets and a 76% surg...- 4 stocks with consistent score improvement and upside potential of up to 31% in 1 year, according to analystsAlthough the indices are in the green on Monday, the market is extremely volatile. The upmove is being attributed to some recovery in oil p...
- India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugsOver the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth ...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Max Healthcare to add 209 beds with Rs 415 crore capex; Q2 network profit rises 10% to Rs 448 croreMax Healthcare has approved a significant capital expenditure to expand bed capacity at its hospitals. The investments include adding 209 b...
- Paras Healthcare shares to list today: Check GMP ahead of debutThe Rs 1,450-crore IPO comprised a fresh issue of 72.15 lakh shares worth Rs 500 crore and an offer for sale (OFS) of 1.37 crore shares agg...
- VCs go deep on single-specialty healthcare with orthopaedics, pain relief betsThe trend is reflected in several recent funding deals. Bengaluru-based Lumov, which makes orthotic products, is in talks to raise Rs 32 cr...
- Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...
- Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2%Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-y...
- Sakar Healthcare posts Rs 11 cr profit in Q2The company said the second quarter growth was supported by new oncology approvals, strong demand across geographies, a better oncology mix...
- YC-backed healthtech startup BioStack raises $9.5 million from Peak XV, DCVC, othersThe Y Combinator-backed startup, which operates across India, the US, Brazil and Argentina, has access to more than 100 million de-identifi...
- Paras Healthcare allotment likely today: Check GMP, key details and how to check statusParas Healthcare IPO allotment is expected to be finalised today after the Rs 1,450-crore issue was subscribed 2.23 times. With the GMP ind...
- Can dogs smell cancer in humans? Bengaluru founders says with AI, dogs can detect seven cancer symptoms with 90% accuracyStartup Dognosis, based in Bengaluru, is creating an AI-driven, dog-assisted breath analysis to detect seven forms of cancer. Co-founded by...
- Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trialJohnson & Johnson reported results from an early-stage trial of their prostate cancer drug JNJ-6143. The trial involved patients with advan...
- VIP culture in hospitals can compromise patient safety, equitable care: AIIMS doctorsAIIMS Delhi doctors discuss the ethical challenges posed by preferential treatment for VIP patients in healthcare. They emphasize that such...
- States urged to enforce ban on reuse of single-use medical devicesThe Directorate General of Health Services has issued a directive to prohibit the reuse of single-use medical devices. Violations by some p...
- Paras Healthcare IPO Day 3: Check GMP, subscription status and key detailsParas Healthcare’s Rs 1,450 crore IPO enters its final bidding day with a muted response, while a grey market premium of around 2% signals ...
- Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leakModerna’s stock price dropped over 25% after trial results for its personalized melanoma vaccine with Merck were disclosed. The decline era...
- AIIMS doctors identify ‘Red Alert Zone’ to reduce risks in complex cancer surgeryAIIMS doctors have recognized two critical anatomical zones during complex cancer surgeries in women. These zones help reduce bleeding and ...
Load More
